Seeking Alpha24/09/2026 19:38:00

Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial

Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial

2 hours ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

First Trust Materials AlphaDEX Fund declares quarterly distribution of $0.2510

2 min ago

First Trust Dorsey Wright International Focus 5 ETF declares $0.094 dividend

2 min ago

First Trust Utilities AlphaDEX Fund declares quarterly distribution of $0.3322

2 min ago

First Trust Industrials/Producer Durables AlphaDEX Fund declares quarterly distribution of $0.2456

3 min ago